NanoSphere Health Sciences Inc. (NSHS.CN)
CAD 0.05
(0.0%)
CAD 0.05
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | - USD | 100.0% |
| 2022 | -0.03 USD | 48.08% |
| 2021 | -0.05 USD | 52.73% |
| 2020 | -0.11 USD | 83.08% |
| 2019 | -0.65 USD | 30.11% |
| 2018 | -0.93 USD | 94.84% |
| 2017 | -18.02 USD | -3433.33% |
| 2016 | -0.51 USD | -104.0% |
| 2015 | -0.25 USD | 75.73% |
| 2014 | -1.03 USD | 98.82% |
| 2013 | -86.93 USD | -9.8% |
| 2012 | -79.17 USD | 67.21% |
| 2011 | -241.44 USD | -187.43% |
| 2010 | -84.00 USD | -221.23% |
| 2009 | 69.29 USD | 103.14% |
| 2008 | -2207.43 USD | -420.45% |
| 2007 | -424.14 USD | -12.99% |
| 2006 | -375.37 USD | -22.83% |
| 2005 | -305.61 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.00 USD | 0.0% |
| 2024 Q2 | -0.01 USD | -47.5% |
| 2023 Q3 | -0.00 USD | 47.37% |
| 2023 Q2 | -0.01 USD | -46.15% |
| 2023 Q1 | -0.01 USD | -13.04% |
| 2023 Q4 | - USD | 100.0% |
| 2023 FY | - USD | 100.0% |
| 2022 Q2 | -0.01 USD | -35.38% |
| 2022 FY | - USD | 48.08% |
| 2022 Q4 | -0.00 USD | 9.8% |
| 2022 Q3 | -0.01 USD | 42.05% |
| 2022 Q1 | -0.01 USD | -114.41% |
| 2021 FY | - USD | 52.73% |
| 2021 Q1 | -0.01 USD | 62.84% |
| 2021 Q2 | -0.02 USD | -91.06% |
| 2021 Q3 | -0.06 USD | -143.83% |
| 2021 Q4 | 0.05 USD | 178.71% |
| 2020 Q1 | -0.04 USD | 82.64% |
| 2020 Q2 | -0.02 USD | 52.53% |
| 2020 Q3 | -0.01 USD | 41.75% |
| 2020 Q4 | -0.03 USD | -175.83% |
| 2020 FY | - USD | 83.08% |
| 2019 FY | - USD | 30.11% |
| 2019 Q4 | -0.25 USD | -56.25% |
| 2019 Q3 | -0.16 USD | -64.95% |
| 2019 Q2 | -0.10 USD | 25.38% |
| 2019 Q1 | -0.13 USD | 65.79% |
| 2018 Q2 | -0.17 USD | 19.05% |
| 2018 FY | - USD | 94.84% |
| 2018 Q4 | -0.38 USD | -192.31% |
| 2018 Q3 | -0.13 USD | 23.53% |
| 2018 Q1 | -0.21 USD | 89.6% |
| 2017 Q1 | -0.06 USD | 19.22% |
| 2017 FY | - USD | -3433.33% |
| 2017 Q4 | -2.02 USD | -2652.04% |
| 2017 Q3 | -0.07 USD | -169.85% |
| 2017 Q2 | -0.03 USD | 53.1% |
| 2016 Q1 | -0.03 USD | 52.56% |
| 2016 FY | - USD | -104.0% |
| 2016 Q3 | -0.64 USD | -1442.17% |
| 2016 Q2 | -0.04 USD | -28.09% |
| 2016 Q4 | -0.07 USD | 88.78% |
| 2015 Q2 | -0.08 USD | -4.45% |
| 2015 Q4 | -0.07 USD | -37.42% |
| 2015 Q3 | -0.05 USD | 35.79% |
| 2015 FY | - USD | 75.73% |
| 2015 Q1 | -0.07 USD | -124.7% |
| 2014 Q4 | 0.30 USD | 124.39% |
| 2014 Q1 | -0.99 USD | 93.09% |
| 2014 FY | - USD | 98.82% |
| 2014 Q2 | -0.78 USD | 21.21% |
| 2014 Q3 | -1.23 USD | -57.69% |
| 2013 Q3 | -6.35 USD | 89.69% |
| 2013 Q4 | -14.32 USD | -125.51% |
| 2013 FY | - USD | -9.8% |
| 2013 Q1 | -6.23 USD | 62.94% |
| 2013 Q2 | -61.58 USD | -888.44% |
| 2012 FY | - USD | 67.21% |
| 2012 Q2 | -26.88 USD | -5.74% |
| 2012 Q3 | -16.68 USD | 37.95% |
| 2012 Q4 | -16.81 USD | -0.78% |
| 2012 Q1 | -25.42 USD | 85.3% |
| 2011 FY | - USD | -187.43% |
| 2011 Q4 | -172.88 USD | -1120.04% |
| 2011 Q2 | -17.78 USD | 41.9% |
| 2011 Q1 | -30.60 USD | -1095.31% |
| 2011 Q3 | -14.17 USD | 20.3% |
| 2010 FY | - USD | -221.23% |
| 2010 Q4 | -2.56 USD | 54.85% |
| 2010 Q3 | -5.67 USD | -92.2% |
| 2010 Q2 | -2.95 USD | 78.45% |
| 2010 Q1 | -13.69 USD | -268.8% |
| 2009 Q1 | -14.96 USD | -102.63% |
| 2009 Q2 | -20.09 USD | -34.29% |
| 2009 Q3 | 98.23 USD | 588.95% |
| 2009 Q4 | 8.11 USD | -91.74% |
| 2009 FY | - USD | 103.14% |
| 2008 Q2 | -69.91 USD | -83.54% |
| 2008 Q3 | -2672.98 USD | -3723.46% |
| 2008 FY | - USD | -420.45% |
| 2008 Q4 | 569.79 USD | 121.32% |
| 2008 Q1 | -38.09 USD | 94.75% |
| 2007 Q1 | -25.20 USD | 85.71% |
| 2007 Q3 | -107.48 USD | -240.13% |
| 2007 Q4 | -724.94 USD | -574.49% |
| 2007 Q2 | -31.60 USD | -25.4% |
| 2007 FY | - USD | -12.99% |
| 2006 Q3 | -36.31 USD | 20.62% |
| 2006 Q1 | -112.08 USD | -156.59% |
| 2006 FY | - USD | -22.83% |
| 2006 Q2 | -45.74 USD | 59.19% |
| 2006 Q4 | -176.40 USD | -385.82% |
| 2005 Q4 | -43.68 USD | 83.49% |
| 2005 Q3 | -264.54 USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -0.45 CAD | 100.0% |
| Asep Medical Holdings Inc | -0.13 CAD | 100.0% |
| BetterLife Pharma Inc. | -0.03 CAD | 100.0% |
| BioVaxys Technology Corp. | -0.06 CAD | 100.0% |
| ChitogenX Inc. | -0.02 CAD | 100.0% |
| Rapid Dose Therapeutics Corp. | -0.04 CAD | 100.0% |
| Defence Therapeutics Inc. | -0.30 CAD | 100.0% |
| Entheon Biomedical Corp. | -0.05 CAD | 100.0% |
| Gemina Laboratories Ltd. | -0.07 CAD | 100.0% |
| Glow Lifetech Corp. | -0.03 CAD | 100.0% |
| Lexston Life Sciences Corp. | -0.02 CAD | 100.0% |
| Pharmala Biotech Holdings Inc. | -0.01 CAD | 100.0% |
| Doseology Sciences Inc. | -0.08 CAD | 100.0% |
| MYND Life Sciences Inc. | -0.03 CAD | 100.0% |
| Nova Mentis Life Science Corp. | -0.01 CAD | 100.0% |
| PharmaTher Holdings Ltd. | -0.04 CAD | 100.0% |
| PreveCeutical Medical Inc. | -0.00 CAD | 100.0% |
| Telescope Innovations Corp. | -0.12 CAD | 100.0% |